<DOC>
	<DOCNO>NCT00961675</DOCNO>
	<brief_summary>The objective study evaluate efficacy FST-201 compare Ciprodex treatment acute otitis externa . This study conduct one site , LBJ Tropical Medical Center , Department Otolaryngology , Pago Pago , American Samoa .</brief_summary>
	<brief_title>FST-201 Treatment Acute Otitis Externa</brief_title>
	<detailed_description>The propose clinical trial evaluate efficacy FST-201 ( dexamethasone 0.1 % ) Otic Suspension vs. FDA-approved drug Ciprodex ( ciprofloxacin 0.3 % , dexamethasone 0.1 % ) Otic Suspension ( Alcon Laboratories , Inc. ) treatment acute otitis externa . Acute otitis externa common inflammatory condition external auditory canal often associate infection , allergy dermatitis . The active ingredient novel dexamethasone suspension identical concentration route administration steroid component approve drug Ciprodex , currently widely-prescribed dexamethasone-containing agent treatment acute otitis externa . We enroll 60 patient ( 30 two separate treatment group ) trial . All patient elect participate study receive either FST-201 Ciprodex . FST-201 Ciprodex mask provided free charge study participant . Patients follow least 15 day ear inflammation either resolve determined need additional intervention . The study conduct attention relevant GCP , ICH , FDA , HIPPA Declaration Helsinki guideline .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>Study participant must : Have clinical diagnosis AOE one ears , define clinical score least 1 edema ( 03 scale ) , 2 overall inflammation ( 03 scale ) 1 tenderness ( absent=0 , present=1 ) Be least 18 year age Visit 1 ( Day 1 , Screening/Baseline ) either sex race Study participant must NOT : Have know sensitivity component study medication Have current infection require systemic antimicrobial treatment Have use topical systemic pain med day Screening/Baseline Visit 1 duration study . Take systemic ( within 30 day ) otic corticosteroid ( within 1 day ) prior Screening/Baseline Visit 1 Current use topical systemic nonsteroidal antiinflammatory drug Use topical otic treatment alcohol , vinegar , hydrogen peroxide astringent medication course study day Screening/Baseline Visit 1 Have take antibiotic within 3 day prior Visit 1 Have sign symptom AOE &gt; 4 week Screening/Baseline Visit 1 Have clinical diagnosis malignant otitis externa ; Have overt fungal AOE Have viral infection pinna tympanic membrane ( i.e herpes zoster ) Have congenital abnormality external auditory canal enrol ear ( ) Have obstructive bony exostosis enrol ear ( ) ; Have mastoid suppurative , noninfectious ear disorder ( e.g , cholesteatoma ) Have malignant tumor external auditory canal Have history otologic surgery . Surgery perform 1 year prior Screening/Baseline Visit 1and limit tympanic membrane allow Have seborrheic dermatitis external auditory canal Have current prior history immunosuppressive disorder Be pregnant , nurse planning pregnancy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>otitis</keyword>
	<keyword>acute</keyword>
	<keyword>externa</keyword>
	<keyword>ear</keyword>
</DOC>